H 4686 proposes establishing a commission to research topical steroid addiction and Topical Steroid Withdrawal Syndrome (TSWS), a condition that can occur after discontinuing long-term use of topical steroid creams or ointments. The commission would examine the health impacts, causes, and challenges associated with these conditions, particularly for individuals who have used topical steroids for skin conditions. This research aims to inform future public health policies and support for affected individuals. The bill is sponsored by Representative Frank A. Moran and falls under the Public Health category.
This bill requires Massachusetts Accountable Care Organizations (ACOs) certified by the Health Policy Commission to provide patient navigation services for individuals with diagnosed mental illness, substance use disorder, or symptoms suggesting these conditions. ACOs must assign certified Patient Engagement Advocates to help patients overcome barriers like finding providers, navigating insurance, scheduling appointments, and coordinating care across specialists. These advocates must provide specific support services, including initial intake assessments, provider matching, and post-treatment follow-up, with patient consent. The requirement applies to all new ACOs immediately and existing ACOs within six months of the bill's effective date.
This bill exempts medications used to treat opioid use disorder from prior authorization requirements under Massachusetts Medicaid. It directly affects Medicaid patients seeking these specific treatments and healthcare providers prescribing them. The key change modifies the definition of "Step Therapy Protocol" to explicitly exclude opioid use disorder medications, ensuring they are covered without needing separate approval from the state health division. This removes administrative barriers for accessing critical treatment options.
HD 3120 requires medical screenings in specific healthcare settings (such as primary care and mental health services) to include questions about gambling habits and frequency, directly affecting patients and healthcare providers conducting these screenings. It establishes a 13-member special commission with state health officials, gambling treatment experts, and representatives from health insurance and gaming organizations to study problem gambling. The commission will assess current research, review screening practices, develop educational materials, and recommend policies to improve prevention, detection, and treatment of gambling addiction. The commission must file annual reports, with the first due by June 30, 2026, and may propose new legislation based on its findings.
This bill requires Massachusetts correctional facilities to provide medication for addiction treatment (MAT) to incarcerated individuals within 24 hours of admission if clinically indicated, and to maintain the same treatment a person was receiving before incarceration. It prohibits denying or discontinuing MAT due to positive drug screens, disciplinary actions, or other barriers, and mandates access to addiction specialists for ongoing care. The bill also requires re-entry planning at least 120 days before release, including referrals for continued treatment, opioid antagonist doses, and assistance with MassHealth benefits. These changes apply to all state and county correctional facilities and aim to ensure consistent care for people with substance use disorders during and after incarceration.
HD 623 requires insurance companies to cover at least 30 days of in-patient treatment for substance abuse disorders, increasing the current minimum from 14 days. The bill directly affects individuals seeking substance abuse treatment and insurance providers operating under Massachusetts law. It amends multiple sections of the state’s insurance statutes (including chapters 32A, 118E, 175, 176A, 176B, and 176G) to replace the figure "14" with "30" in coverage requirements. This is a concrete policy change to expand mandated treatment duration, without altering other insurance terms or creating new programs.
This bill requires all public school districts, charter schools, and approved private schools to integrate opioid use disorder education into existing health curricula. It mandates teaching specific topics, including opioid types, overdose identification, naloxone use and access, reducing stigma around naloxone, and medical amnesty protections for laypeople who assist during overdoses. The education standards must be incorporated into current health classes without creating new standalone courses. The bill does not impose new funding requirements but allows the department to seek external funding for implementation.
By Mr. Fernandes, a petition (accompanied by bill, Senate, No. 863) of Dylan A. Fernandes for legislation relative to coverage for non-opioid pain medications for chronic pain. Health Care Financing.
By Mr. Cyr, a petition (accompanied by bill, Senate, No. 1388) of Julian Cyr for legislation to build resiliency in communities through mental health. Mental Health, Substance Use and Recovery.
By Representative Gordon of Bedford, a petition (accompanied by bill, House, No. 2210) of Kenneth I. Gordon relative to inpatient mental health care treatment. Mental Health, Substance Use and Recovery.